[1] Rodeghiero F,Stasi R,Gernsheimer T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an international working group[J].Blood,2009,113(11),2389-2393. [2] Yong M, Schoonen WM, Li L ,et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database[J].Br J Haematol,2010,149(6): 855-864. [3] Rajantie J.Idiopathic thrombocytopenic purpura(ITP)in children[J]Duodecim,2011,127(19):2081-2086. [4] 中华医学会儿科学分会血液学组,《中华儿科杂志》编辑委员会.儿童原发性免疫性血小板减少症诊疗建议[J].中华儿科杂志, 2013, 51(5): 382-384. [5] 孟美丽,黄瑞滨.特发性血小板减少性紫癜患者血小板特异性抗体的表达、意义及检测 [J].江西医药,2009,44(3):279-282. [6] 李培岭.急性免疫性血小板减少症患儿免疫状态研究[J].中国实用儿科杂志,2014,29(7):548-550. [7] 牛忆军.特发性血小板减少性紫癜患者T淋巴细胞亚群及IL-2、IFN-γ、IL-4检测的临床意义[J].检验医学,2006,21(4):427-428. [8] Golovina TN,Vonderherde RH.Regulatory T cells overcoming suppression of T-cells immunity[J].Cancer J,2010,16(4):342-347. [9] Buckner JH.Mechanisms of impaired regulation by CD4(+)CD25(+) regulatory T cells in human autoimmune diseases[J].Nat Rev Immunol,2010,10(12):849-859. [10] Cines DB,McMillan R.Pathogenesis of chronic immune thrombocytopenic Purpura[J].Curropin Hematol,2007,14(5):511-514. [11] 常涛涛.原发性ITP患儿外周血血小板相关抗体和淋巴细胞亚群的变化及临床意义[J].中国医学创新,2013,10(9):1-2. [12] Johasson U, Macey M G, Kenny D, et al. The role of natural killer T cells in immune thrombocytopenia: is strong in vitro NKT cell activity related to the development of remission[J]. Br J Haematol,2005,129(4):564-565. [13] Lazarus AH,Joy T,Crow AR.Analysis of transmembrane signalling and T cell defects assoiated with idiopathic thrombocytopenic purpura[J].Acta Padiatr Suppl,1998,424:21-25.
2017, Vol. 34 
